Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

MabVax Receives Patent for Fully Human Antibodies Targeting the Antigen GD2

americanpharmaceuticalreviewMay 18, 2018

Tag: MabVax Receives Patent , Fully Human , the Antigen GD2

PharmaSources Customer Service